osimertinib,pembrolizumab
merck,novocure,astrazeneca
['lcsm,(-blcsm)', 'lunar ', 'osimertinib', '$mrk']
big unmet need in patients with egfr mutations that have progressed on osimertinib. interested to see if any of these patients are in the lunar study and how they do on ttf + checkpoint. checkpoint + chemo does not work #asco2023 #lcsm $nvcr $mrk 
Gamechanger small-mid cap med device & bio companies | Opinions only not advice | T1D | $NVCR $LNTH $SWAV $PNT $ALDX $ZLAB | Remember All Fintwit Darlings Die